Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 93

1.

Increase in Superficial Dose in Whole-Breast Irradiation With Halcyon Straight-Through Linac Compared With Traditional C-arm Linac With Flattening Filter: In vivo Dosimetry and Planning Study.

O'Grady F, Barsky AR, Anamalayil S, Freedman GM, Kennedy C, Cai B, Laugeman E, Dong L, Hugo GD, Metz JM, Mutic S, Taunk NK, Li T.

Adv Radiat Oncol. 2019 Aug 21;5(1):120-126. doi: 10.1016/j.adro.2019.07.011. eCollection 2020 Jan-Feb.

2.

Comparative Effectiveness of Proton vs Photon Therapy as Part of Concurrent Chemoradiotherapy for Locally Advanced Cancer.

Baumann BC, Mitra N, Harton JG, Xiao Y, Wojcieszynski AP, Gabriel PE, Zhong H, Geng H, Doucette A, Wei J, O'Dwyer PJ, Bekelman JE, Metz JM.

JAMA Oncol. 2019 Dec 26. doi: 10.1001/jamaoncol.2019.4889. [Epub ahead of print]

PMID:
31876914
3.

Dosimetric Characterization of the Dual Layer MLC System for an O-Ring Linear Accelerator.

Kim MM, Bollinger D, Kennedy C, Zou W, Scheuermann R, Teo BK, Metz JM, Dong L, Li T.

Technol Cancer Res Treat. 2019 Jan-Dec;18:1533033819883641. doi: 10.1177/1533033819883641.

4.

Initial Clinical Experience Treating Patients with Breast Cancer on a 6-MV Flattening-Filter-Free O-Ring Linear Accelerator.

Barsky AR, O'Grady F, Kennedy C, Taunk NK, Dong L, Metz JM, Li T, Freedman GM.

Adv Radiat Oncol. 2019 Jun 8;4(4):571-578. doi: 10.1016/j.adro.2019.05.006. eCollection 2019 Oct-Dec.

5.

Proton Therapy.

LaRiviere MJ, Santos PMG, Hill-Kayser CE, Metz JM.

Hematol Oncol Clin North Am. 2019 Dec;33(6):989-1009. doi: 10.1016/j.hoc.2019.08.006. Epub 2019 Oct 1. Review.

PMID:
31668216
6.

Evaluating the Impact of Secure Mobile Messaging on Communication and Cancer Care Team Satisfaction in a Large Radiation Oncology Clinic.

Arscott WT, Gray K, Kuska D, Nagda S, Lustig R, Alonso-Basanta M, Metz JM, Jones J.

J Oncol Pract. 2019 Aug;15(8):e733-e738. doi: 10.1200/JOP.18.00539. Epub 2019 Jul 2.

PMID:
31265351
7.

Characterization of the Megavoltage Cone-Beam Computed Tomography (MV-CBCT) System on HalcyonTM for IGRT: Image Quality Benchmark, Clinical Performance, and Organ Doses.

Malajovich I, Teo BK, Petroccia H, Metz JM, Dong L, Li T.

Front Oncol. 2019 Jun 12;9:496. doi: 10.3389/fonc.2019.00496. eCollection 2019.

8.

Pencil Beam Scanning Proton Beam Chemoradiation Therapy With 5-Fluorouracil and Mitomycin-C for Definitive Treatment of Carcinoma of the Anal Canal: A Multi-institutional Pilot Feasibility Study.

Wo JY, Plastaras JP, Metz JM, Jiang W, Yeap BY, Drapek LC, Adams J, Baglini C, Ryan DP, Murphy JE, Parikh AR, Allen JN, Clark JW, Blaszkowsky LS, DeLaney TF, Ben-Josef E, Hong TS.

Int J Radiat Oncol Biol Phys. 2019 Sep 1;105(1):90-95. doi: 10.1016/j.ijrobp.2019.04.040. Epub 2019 May 22.

PMID:
31128146
9.

Spine SBRT With Halcyon™: Plan Quality, Modulation Complexity, Delivery Accuracy, and Speed.

Petroccia HM, Malajovich I, Barsky AR, Ghiam AF, Jones J, Wang C, Zou W, Teo BK, Dong L, Metz JM, Li T.

Front Oncol. 2019 Apr 26;9:319. doi: 10.3389/fonc.2019.00319. eCollection 2019.

10.

Design and commissioning of an image-guided small animal radiation platform and quality assurance protocol for integrated proton and x-ray radiobiology research.

Kim MM, Irmen P, Shoniyozov K, Verginadis II, Cengel KA, Koumenis C, Metz JM, Dong L, Diffenderfer ES.

Phys Med Biol. 2019 Jul 4;64(13):135013. doi: 10.1088/1361-6560/ab20d9.

PMID:
31075786
11.
12.

Impact of Multi-leaf Collimator Parameters on Head and Neck Plan Quality and Delivery: A Comparison between Halcyon™ and Truebeam® Treatment Delivery Systems.

Li T, Scheuermann R, Lin A, Teo BK, Zou W, Swisher-McClure S, Alonso-Basanta M, Lukens JN, Fotouhi Ghiam A, Kennedy C, Kim MM, Mihailidis D, Metz JM, Dong L.

Cureus. 2018 Nov 28;10(11):e3648. doi: 10.7759/cureus.3648.

13.

Patient-Reported Survivorship Care Practices and Late Effects After Treatment of Hodgkin and Non-Hodgkin Lymphoma.

Frick MA, Vachani CC, Hampshire MK, Bach C, Arnold-Korzeniowski K, Metz JM, Hill-Kayser CE.

JCO Clin Cancer Inform. 2018 Dec;2:1-10. doi: 10.1200/CCI.18.00015.

14.

Whole Breast Irradiation with Halcyon™ 2.0: Workflow and Efficiency of Field-in-Field Treatment with Dynamic Beam Flattening Technique and kV Cone Beam Computed Tomography.

Kennedy C, Freedman G, Taunk N, Scheuermann R, Dong L, Metz JM, Li T.

Cureus. 2018 Oct 29;10(10):e3510. doi: 10.7759/cureus.3510.

15.

Assessing the Validity of Clinician Advice That Patients Avoid Use of Topical Agents Before Daily Radiotherapy Treatments.

Baumann BC, Verginadis II, Zeng C, Bell B, Koduri S, Vachani C, MacArthur KM, Solberg TD, Koumenis C, Metz JM.

JAMA Oncol. 2018 Dec 1;4(12):1742-1748. doi: 10.1001/jamaoncol.2018.4292.

16.

Patient-reported outcomes in head and neck cancer: prospective multi-institutional patient-reported toxicity.

Peach MS, Trifiletti DM, Vachani C, Arnold-Korzeniowski K, Bach C, Hampshire M, Metz JM, Hill-Kayser CE.

Patient Relat Outcome Meas. 2018 Jul 27;9:245-252. doi: 10.2147/PROM.S153919. eCollection 2018.

17.

Identifying barriers to cancer survivors sharing their survivorship care plans with their healthcare provider.

Benci JL, Vachani CC, Bach C, Arnold-Korzeniowski K, Hampshire MK, Metz JM, Hill-Kayser CE.

J Cancer Surviv. 2018 Oct;12(5):632-638. doi: 10.1007/s11764-018-0699-3. Epub 2018 Jul 3.

PMID:
29971637
18.

Comparative Effectiveness of Neoadjuvant Chemoradiation Versus Upfront Surgery in the Management of Recto-Sigmoid Junction Cancer.

Venigalla S, Chowdhry AK, Wojcieszynski AP, Lukens JN, Plastaras JP, Metz JM, Ben-Josef E, Mahmoud NN, Reiss KA, Shabason JE.

Clin Colorectal Cancer. 2018 Sep;17(3):e557-e568. doi: 10.1016/j.clcc.2018.05.005. Epub 2018 May 17.

19.

FDG-Avid Focal Liver Reaction From Proton Therapy in a Patient With Primary Esophageal Adenocarcinoma.

Ahmed HS, Pantel AR, Metz JM, Plastaras JP, Farwell MD.

Clin Nucl Med. 2018 May;43(5):e139-e141. doi: 10.1097/RLU.0000000000002035.

20.

Stereotactic Body Radiation Therapy (SBRT) for Hepatocellular Carcinoma: High Rates of Local Control With Low Toxicity.

Baumann BC, Wei J, Plastaras JP, Lukens JN, Damjanov N, Hoteit M, Hsu C, Levine M, Mondschein J, Nadolski G, Olthoff K, Reiss KA, Rosen M, Siegelman E, Metz JM, Ben-Josef E.

Am J Clin Oncol. 2018 Mar 16. doi: 10.1097/COC.0000000000000435. [Epub ahead of print]

PMID:
29553972
21.

A phase I dose escalation trial of nab-paclitaxel and fixed dose radiation in patients with unresectable or borderline resectable pancreatic cancer.

Shabason JE, Chen J, Apisarnthanarax S, Damjanov N, Giantonio B, Loaiza-Bonilla A, O'Dwyer PJ, O'Hara M, Reiss KA, Teitelbaum U, Wissel P, Drebin JA, Vollmer C, Kochman M, Mick R, Vergara N, Jhala N, Doucette A, Lukens JN, Plastaras JP, Metz JM, Ben-Josef E.

Cancer Chemother Pharmacol. 2018 Mar;81(3):609-614. doi: 10.1007/s00280-018-3519-6. Epub 2018 Jan 23.

PMID:
29362902
22.

Survivorship after treatment of pancreatic cancer: insights via an Internet-based survivorship care plan tool.

Frick MA, Vachani CC, Hampshire MK, Bach C, Arnold-Korzeniowski K, Metz JM, Hill-Kayser CE.

J Gastrointest Oncol. 2017 Oct;8(5):890-896. doi: 10.21037/jgo.2017.08.07. Review.

23.

Proton beam reirradiation for locally recurrent pancreatic adenocarcinoma.

Boimel PJ, Berman AT, Li J, Apisarnthanarax S, Both S, Lelionis K, Larson GL, Teitelbaum U, Lukens JN, Ben-Josef E, Metz JM, Plastaras JP.

J Gastrointest Oncol. 2017 Aug;8(4):665-674. doi: 10.21037/jgo.2017.03.04.

24.

Neoadjuvant chemoradiation is associated with improved overall survival in older patients with esophageal cancer.

Guttmann DM, Mitra N, Metz JM, Plastaras J, Feng W, Swisher-McClure S.

J Geriatr Oncol. 2018 Jan;9(1):40-46. doi: 10.1016/j.jgo.2017.08.010. Epub 2017 Sep 6.

PMID:
28887066
25.

Survivorship care planning in skin cancer: An unbiased statistical approach to identifying patterns of care-plan use.

Benci JL, Minn AJ, Vachani CC, Bach C, Arnold-Korzeniowski K, Hampshire MK, Metz JM, Hill-Kayser CE.

Cancer. 2018 Jan 1;124(1):183-191. doi: 10.1002/cncr.30985. Epub 2017 Sep 8.

26.

Avoiding antiperspirants during breast radiation therapy: Myth or sound advice?

Baumann BC, Zeng C, Freedman GM, Verginadis II, MacArthur KM, Lin LL, Vachani C, Koumenis C, Solberg TD, Metz JM.

Radiother Oncol. 2017 Aug;124(2):204-207. doi: 10.1016/j.radonc.2017.06.021. Epub 2017 Jul 18.

PMID:
28733055
27.

Survivorship and the chronic cancer patient: Patterns in treatment-related effects, follow-up care, and use of survivorship care plans.

Frick MA, Vachani CC, Bach C, Hampshire MK, Arnold-Korzeniowski K, Metz JM, Hill-Kayser CE.

Cancer. 2017 Nov 1;123(21):4268-4276. doi: 10.1002/cncr.30862. Epub 2017 Jun 27.

28.

Improved Overall Survival with Aggressive Primary Tumor Radiotherapy for Patients with Metastatic Esophageal Cancer.

Guttmann DM, Mitra N, Bekelman J, Metz JM, Plastaras J, Feng W, Swisher-McClure S.

J Thorac Oncol. 2017 Jul;12(7):1131-1142. doi: 10.1016/j.jtho.2017.03.026. Epub 2017 Apr 28.

29.

Survivorship after lower gastrointestinal cancer: Patient-reported outcomes and planning for care.

Frick MA, Vachani CC, Hampshire MK, Bach C, Arnold-Korzeniowski K, Metz JM, Hill-Kayser CE.

Cancer. 2017 May 15;123(10):1860-1868. doi: 10.1002/cncr.30527. Epub 2017 Jan 5.

30.

An automated electronic system for managing radiation treatment plan peer review reduces missed reviews at a large, high-volume academic center.

Gabriel PE, Woodhouse KD, Lin A, Finlay JC, Young RB, Volz E, Hahn SM, Metz JM, Maity A.

Pract Radiat Oncol. 2016 Nov - Dec;6(6):e307-e314. doi: 10.1016/j.prro.2016.03.004. Epub 2016 Mar 16.

PMID:
27155763
31.

Feasibility Study of an Electronic Interface Between Internet-Based Survivorship Care Plans and Electronic Medical Records.

Hill-Kayser CE, Jacobs LA, Gabriel P, Palmer SC, Hampshire MK, Vachani C, Edge SB, Metz JM.

J Oncol Pract. 2016 Apr;12(4):e380-7. doi: 10.1200/JOP.2015.006841. Epub 2016 Mar 22.

PMID:
27006355
32.

A Prospective Study of Proton Beam Reirradiation for Esophageal Cancer.

Fernandes A, Berman AT, Mick R, Both S, Lelionis K, Lukens JN, Ben-Josef E, Metz JM, Plastaras JP.

Int J Radiat Oncol Biol Phys. 2016 May 1;95(1):483-7. doi: 10.1016/j.ijrobp.2015.12.005. Epub 2015 Dec 14.

PMID:
26847847
33.

Cancer survivors' perspectives on delivery of survivorship care by primary care physicians: an internet-based survey.

Nyarko E, Metz JM, Nguyen GT, Hampshire MK, Jacobs LA, Mao JJ.

BMC Fam Pract. 2015 Oct 20;16:143. doi: 10.1186/s12875-015-0367-x.

34.

Adjuvant Radiation Therapy Treatment Time Impacts Overall Survival in Gastric Cancer.

McMillan MT, Ojerholm E, Roses RE, Plastaras JP, Metz JM, Mamtani R, Karakousis GC, Fraker DL, Drebin JA, Stripp D, Ben-Josef E, Datta J.

Int J Radiat Oncol Biol Phys. 2015 Oct 1;93(2):326-36. doi: 10.1016/j.ijrobp.2015.05.025. Epub 2015 May 21.

PMID:
26232857
35.

Late effects in survivors of central nervous system tumors: reports by patients and proxies.

Sloane K, Vachani C, Hampshire MK, Metz JM, Hill-Kayser CE.

J Cancer Surviv. 2016 Apr;10(2):234-40. doi: 10.1007/s11764-015-0469-4. Epub 2015 Jul 15.

PMID:
26174075
36.

Comparative assessment of liver tumor motion using cine-magnetic resonance imaging versus 4-dimensional computed tomography.

Fernandes AT, Apisarnthanarax S, Yin L, Zou W, Rosen M, Plastaras JP, Ben-Josef E, Metz JM, Teo BK.

Int J Radiat Oncol Biol Phys. 2015 Apr 1;91(5):1034-40. doi: 10.1016/j.ijrobp.2014.12.048.

PMID:
25832694
37.

Pencil-beam scanning proton therapy for anal cancer: a dosimetric comparison with intensity-modulated radiotherapy.

Ojerholm E, Kirk ML, Thompson RF, Zhai H, Metz JM, Both S, Ben-Josef E, Plastaras JP.

Acta Oncol. 2015;54(8):1209-17. doi: 10.3109/0284186X.2014.1002570. Epub 2015 Mar 3.

PMID:
25734796
38.

Clinical decision tool for optimal delivery of liver stereotactic body radiation therapy: Photons versus protons.

Gandhi SJ, Liang X, Ding X, Zhu TC, Ben-Josef E, Plastaras JP, Metz JM, Both S, Apisarnthanarax S.

Pract Radiat Oncol. 2015 Jul-Aug;5(4):209-18. doi: 10.1016/j.prro.2015.01.004. Epub 2015 Feb 18.

PMID:
25703530
39.

A dosimetric comparison of proton and photon therapy in unresectable cancers of the head of pancreas.

Thompson RF, Mayekar SU, Zhai H, Both S, Apisarnthanarax S, Metz JM, Plastaras JP, Ben-Josef E.

Med Phys. 2014 Aug;41(8):081711. doi: 10.1118/1.4887797.

PMID:
25086521
40.

Clinical utility of integrated positron emission tomography/computed tomography imaging in the clinical management and radiation treatment planning of locally advanced rectal cancer.

Whaley JT, Fernandes AT, Sackmann R, Plastaras JP, Teo BK, Grover S, Perini RF, Metz JM, Pryma DA, Apisarnthanarax S.

Pract Radiat Oncol. 2014 Jul-Aug;4(4):226-32. doi: 10.1016/j.prro.2013.09.002. Epub 2013 Oct 22.

PMID:
25012830
41.

Proton therapy in adjuvant treatment of gastric cancer: planning comparison with advanced x-ray therapy and feasibility report.

Dionisi F, Avery S, Lukens JN, Ding X, Kralik J, Kirk M, Roses RE, Amichetti M, Metz JM, Plastaras JP.

Acta Oncol. 2014 Oct;53(10):1312-20. doi: 10.3109/0284186X.2014.912351. Epub 2014 May 5.

PMID:
24797885
42.

Impact of internet-based cancer survivorship care plans on health care and lifestyle behaviors.

Hill-Kayser CE, Vachani CC, Hampshire MK, Di Lullo G, Jacobs LA, Metz JM.

Cancer. 2013 Nov 1;119(21):3854-60. doi: 10.1002/cncr.28286. Epub 2013 Aug 6.

43.

Abdominal and pancreatic motion correlation using 4D CT, 4D transponders, and a gating belt.

Betancourt R, Zou W, Plastaras JP, Metz JM, Teo BK, Kassaee A.

J Appl Clin Med Phys. 2013 May 6;14(3):4060. doi: 10.1120/jacmp.v14i3.4060.

44.

Toxicity study of gemcitabine, oxaliplatin, and bevacizumab, followed by 5-fluorouracil, oxaliplatin, bevacizumab, and radiotherapy, in patients with locally advanced pancreatic cancer.

Sohal DP, Metz JM, Sun W, Giantonio BJ, Plastaras JP, Ginsberg G, Kochman ML, Teitelbaum UR, Harlacker K, Heitjan DF, Feldman MD, Drebin JA, O'Dwyer PJ.

Cancer Chemother Pharmacol. 2013 Jun;71(6):1485-91. doi: 10.1007/s00280-013-2147-4. Epub 2013 Mar 27.

PMID:
23532207
45.

Dose perturbations by electromagnetic transponders in the proton environment.

Dolney D, McDonough J, Vapiwala N, Metz JM.

Phys Med Biol. 2013 Mar 7;58(5):1495-505. doi: 10.1088/0031-9155/58/5/1495. Epub 2013 Feb 13.

PMID:
23403457
46.

The impact of radiation therapy sequencing on survival and cardiopulmonary mortality in the combined modality treatment of patients with esophageal cancer.

Wojcieszynski AP, Berman AT, Wan F, Plastaras JP, Metz JM, Mitra N, Apisarnthanarax S.

Cancer. 2013 Jun 1;119(11):1976-84. doi: 10.1002/cncr.27970. Epub 2013 Feb 7.

47.

Dosimetric consequences of pancreatic tumor motion when predetermined treatment margins are employed during intensity-modulated radiation therapy.

Shen J, Metz JM, Zhu TC, Panetta J, Finlay JC, Xu-Welliver M, Plastaras JP, Bar Ad V, Both S.

J BUON. 2012 Jul-Sep;17(3):526-32.

PMID:
23033294
48.

Palliative care in the management of lung cancer: analgesic utilization and barriers to optimal pain management.

Simone CB 2nd, Vapiwala N, Hampshire MK, Metz JM.

J Opioid Manag. 2012 Jan-Feb;8(1):9-16.

PMID:
22479880
49.

Cosmetic outcomes and complications reported by patients having undergone breast-conserving treatment.

Hill-Kayser CE, Vachani C, Hampshire MK, Di Lullo GA, Metz JM.

Int J Radiat Oncol Biol Phys. 2012 Jul 1;83(3):839-44. doi: 10.1016/j.ijrobp.2011.08.013. Epub 2011 Dec 2.

PMID:
22137022
50.

Patient reported late effects of gynecological cancer treatment.

Grover S, Hill-Kayser CE, Vachani C, Hampshire MK, DiLullo GA, Metz JM.

Gynecol Oncol. 2012 Mar;124(3):399-403. doi: 10.1016/j.ygyno.2011.11.034. Epub 2011 Nov 23.

PMID:
22119992

Supplemental Content

Support Center